Probiotics for Better Gastrointestinal Tolerance in Iron Deficiency Anemia
This study aims to evaluate if taking Lactobacillus plantarum 299v probiotic with oral iron can improve gastrointestinal comfort and treatment adherence in people with iron deficiency anemia.
Lactobacillus plantarum 299v probiotic support
Iron Deficiencies+6
+ Anemia
+ Anemia, Hypochromic
Treatment Study
Summary
Study start date: September 1, 2022
Actual date on which the first participant was enrolled.This study is focused on improving the treatment experience for adults with newly diagnosed iron deficiency anemia (IDA). It aims to assess whether adding a probiotic, L. plantarum 299v, to the standard iron replacement therapy (IRT) can reduce uncomfortable digestive issues that often accompany iron supplements. The study includes patients who have not previously received iron treatment and excludes those with conditions like celiac disease or irritable bowel syndrome. This research is important as it seeks to make iron treatment more tolerable, potentially improving adherence and outcomes for patients with IDA. Participants in the study are randomly divided into two groups: one receives just the iron supplement (ferrous sulfate) at 100 mg daily, while the other also takes a daily probiotic for the first month. Researchers measure symptoms like nausea and constipation at the start, after 30 days, and throughout the three-month treatment to see if the probiotic helps. They also monitor iron levels in the blood to evaluate the effectiveness of the treatment. The study considers how many patients stop treatment due to discomfort, aiming to find if the probiotic can help reduce this issue.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.295 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Antalya Training and Research Hospital
Antalya, Turkey (Türkiye)Open Antalya Training and Research Hospital in Google Maps